Minor cannabinoids as metabolic therapeutics

Mouse experiments show that whole‑plant cannabis extracts (containing minor cannabinoids) produced weight loss plus improved glucose regulation, whereas pure THC caused weight loss but left glucose dysregulation. This suggests non‑THC compounds in cannabis could be isolated and developed as non‑intoxicating treatments for obesity‑related glucose problems. — If confirmed in humans, the finding reframes cannabis from an appetite anecdote to a source of novel metabolic drug leads and demands careful public‑health communication.